X
News
Home
About Us
Company
Quality and Regulatory
Innovation
Careers
Modern Slavery Act
Gender Pay Report
Sealantis
Biomatlante
Our Technologies
Alginates
Collagen
Cyanoacrylates
Foam
Hydrocolloid
Hydrogels
Internal Sealants
Oxidised Cellulose
Sutures
Our Divisions
Surgical
LiquiBand®
RESORBA®
Partners
Request Information
Woundcare
ActivHeal
®
Foams
Hydrogels
Hydrocolloids
Alginates
Film
Request Information
Downloads
Investor Relations
At a Glance
Financial Highlights
Our Business
Our Investment Case
Our Vision and Strategy
Our Business Model
Environmental, Social and Governance
Corporate Governance
Corporate Governance
Statement of Compliance
Stakeholder Engagement (s172)
Board of Directors
Board Committees
Audit Committee
Nomination Committee
Remuneration Committee
Directors’ Responsibilities
Key Performance Indicators
Senior Management
Shareholder Information
AGM
AIM Rule 26 Information
Warning to Shareholders
Shareholder Analysis
Financial Calendar
Company Documents
Advisors
Analysts
Share Price Information
Shareholder Price Data
Share Price Calculator
Share Terms Glossary
Regulatory News (RNS)
Financial Reports
Annual / Interim Reports
Results & Presentations
FAQs
RNS Alert Service
Contact
Our Locations
Make an Enquiry
Home
About Us
Company
Quality and Regulatory
Innovation
Careers
Modern Slavery Act
Gender Pay Report
Sealantis
Biomatlante
Our Technologies
Alginates
Collagen
Cyanoacrylates
Foam
Hydrocolloid
Hydrogels
Internal Sealants
Oxidised Cellulose
Sutures
Our Divisions
Surgical
LiquiBand®
RESORBA®
Partners
Request Information
Woundcare
ActivHeal
®
Foams
Hydrogels
Hydrocolloids
Alginates
Film
Request Information
Downloads
Investor Relations
At a Glance
Financial Highlights
Our Business
Our Investment Case
Our Vision and Strategy
Our Business Model
Environmental, Social and Governance
Corporate Governance
Corporate Governance
Statement of Compliance
Stakeholder Engagement (s172)
Board of Directors
Board Committees
Audit Committee
Nomination Committee
Remuneration Committee
Directors’ Responsibilities
Key Performance Indicators
Senior Management
Shareholder Information
AGM
AIM Rule 26 Information
Warning to Shareholders
Shareholder Analysis
Financial Calendar
Company Documents
Advisors
Analysts
Share Price Information
Shareholder Price Data
Share Price Calculator
Share Terms Glossary
Regulatory News (RNS)
Financial Reports
Annual / Interim Reports
Results & Presentations
FAQs
RNS Alert Service
Contact
Our Locations
Make an Enquiry
Home
About Us
Careers
Careers
About Us
Company
Quality and Regulatory
Innovation
Careers
Sealantis
Biomatlante
News
Regulatory News
Advanced Medical Solutions announces its unaudited interim results for the six months ended 30 June 2021
Read More
View More News
Holding(s) in Company
Holding in Company
11th October 2021
Block listing announcement
Blocklisting Interim Review
17th September 2021
Interim Results
Interim Results
15th September 2021
View All RNS
